As exemplarily shown in Fig. 3a–d for clear cell and Fig. 4a–d for serous carcinoma, tumor-infiltrating leukocytes showed a high intracellular level of ACTBL2 as well as a strong expression of membrane-bound CD44. This evidence concerns the gene ACTBL2 and serous adenocarcinoma.